Envoy Medical (COCH) Asset Writedowns and Impairment (2022 - 2026)
Envoy Medical (COCH) reported Asset Writedowns and Impairment of $12000.0 for Q1 2026, up 152.17% on a YoY basis from $4758.6 in Q1 2025, and up 137.5% sequentially from -$32000.0 in Q4 2025.
Envoy Medical (COCH) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of Asset Writedowns and Impairment data on file, last reported at $12000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 152.17% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2026 stood at $71000.0 (down 72.9% YoY), and the FY2025 full-year result was $36000.0, down 52.63% from the prior year.
- Asset Writedowns and Impairment improved to $12000.0 in Q1 2026, from -$32000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $173000.0 in Q2 2024 to a low of -$105000.0 in Q3 2023.
- A 5-year average of $15083.3 and a median of $4500.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment jumped 5866.67% in 2024 and tumbled 125.84% in 2025, its largest moves.
- Tracing COCH's Asset Writedowns and Impairment over 5 years: stood at -$30000.0 in 2022, then jumped by 176.67% to $23000.0 in 2023, then jumped by 652.17% to $173000.0 in 2024, then plunged by 118.5% to -$32000.0 in 2025, then jumped by 137.5% to $12000.0 in 2026.
- Business Quant data shows COCH's Asset Writedowns and Impairment at $12000.0 in Q1 2026, -$32000.0 in Q4 2025, and $58000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | -23,000.00 |
| Mar 31, 2025 | -23,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | -105,000.00 |
| Sep 30, 2023 | -105,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Jun 30, 2023 | -3,000.00 |